Division of Cardiology, Stavanger University Hospital, PO 8400, 4068, Stavanger, Norway.
Eur Heart J. 2014 Feb;35(6):395-402. doi: 10.1093/eurheartj/eht482. Epub 2013 Nov 18.
We investigated the temporal changes in circulating levels of markers of extracellular cardiac matrix (ECCM) turnover and their relationship with infarct size (IS), ejection fraction (EF), and left ventricular (LV) volumes, determined by serial cardiac magnetic resonance (CMR) imaging in patients with first-time ST-elevation myocardial infarction (STEMI).
Forty-two patients with a first-time STEMI, successfully revascularized by primary percutaneous coronary intervention (pPCI) had serum samples taken prior to pPCI, 2, 7 days, 2 months, and 1 year following STEMI for the analysis of the markers of collagen synthesis, and collagen degradation. Late enhancement and cine CMR was performed on Days 2, 7, 2 months, and 1-year post-STEMI. There was a significant increase in type I collagen degradation following STEMI that was not accompanied by an increase in collagen type I synthesis until 2 months and 1 year. In contrast to the delay in type I collagen synthesis, there was an immediate increase in type III collagen synthesis that was sustained for 1 year. N-terminal procollagen type I levels assessed prior to pPCI were predictive of adverse LV remodelling at all CMR time-points.
Our findings indicate a net type I collagen breakdown in the first week following STEMI compensated by an early increase in collagen type III synthesis. There is an increase in both type I and III collagen synthesis markers at 2 months and 1 year, indicating a persistent increase in collagen turnover even in these apparently successfully treated patients.
我们研究了首次 ST 段抬高型心肌梗死(STEMI)患者循环细胞外心肌基质(ECCM)转化标志物水平的时间变化及其与梗死面积(IS)、射血分数(EF)和左心室(LV)容积的关系,这些通过连续心脏磁共振(CMR)成像确定。
42 例首次 STEMI 患者,经直接经皮冠状动脉介入治疗(pPCI)成功再血管化,在 pPCI 前、STEMI 后 2、7 天、2 个月和 1 年采集血清样本,用于分析胶原合成和胶原降解标志物。在 STEMI 后第 2、7、2 个月和 1 年进行晚期强化和电影 CMR。STEMI 后 I 型胶原降解明显增加,但直到 2 个月和 1 年才增加 I 型胶原合成。与 I 型胶原合成延迟相反,III 型胶原合成立即增加,并持续 1 年。pPCI 前测定的 N 端前胶原 I 水平可预测所有 CMR 时间点的不良 LV 重构。
我们的研究结果表明,STEMI 后第一周存在净 I 型胶原分解,由早期 III 型胶原合成增加代偿。2 个月和 1 年时 I 型和 III 型胶原合成标志物均增加,表明即使在这些治疗效果明显的患者中,胶原转化也持续增加。